LEADER 01972nam 2200481I 450 001 9910709961903321 005 20190225142415.0 035 $a(CKB)5470000002474647 035 $a(OCoLC)1078689563 035 $a(EXLCZ)995470000002474647 100 $a20181211d2018 ua 0 101 0 $aeng 135 $aur||||||||||| 181 $ctxt$2rdacontent 182 $cc$2rdamedia 183 $acr$2rdacarrier 200 10$aGold panning $eguide to recreational gold panning on the Kenai Peninsula, Chugach National Forest, Alaska 205 $aRev 2018. 210 1$a[Alaska] :$cU.S. Department of the Interior, Bureau of Land Management,$d2018. 215 $a1 online resource (ii, 26 pages) $cillustrations (some color), color maps 300 $a"1997 edition, written by Carol Huber and Joseph Kurtak ; 2010 and 2018 editions, edited by John Hoppe and Karen J. Laubenstein. 2018 revision is a joint project of the U.S. Forest Service, Chugach National Forest and the Bureau of Land Management in Alaska"--Page 2 of cover. 300 $a"First printing by U.S. Forest Service in 2001. BLM/AK/GI-10-008+8362+9320 Rev 2018"--Page 4 of cover. 320 $aIncludes bibliographical references (page 25). 517 $aGold panning 606 $aGold panning$zAlaska$zKenai Peninsula 606 $aGold mines and mining$zAlaska$zKenai Peninsula 606 $aProspecting$zAlaska$zKenai Peninsula 606 $aPlacer mining$zAlaska$zKenai Peninsula 607 $aChugach National Forest (Alaska) 615 0$aGold panning 615 0$aGold mines and mining 615 0$aProspecting 615 0$aPlacer mining 700 $aHuber$b Carol$01412433 702 $aKurtak$b Joseph M. 712 02$aChugach National Forest (Agency : U.S.), 712 02$aUnited States.$bBureau of Land Management, 801 0$bGPO 801 1$bGPO 906 $aBOOK 912 $a9910709961903321 996 $aGold panning$93528507 997 $aUNINA LEADER 01783nam 2200397 450 001 996279567203316 005 20231206174003.0 010 $a1-55937-602-3 024 7 $a10.1109/IEEESTD.1986.81070 035 $a(CKB)3780000000089225 035 $a(NjHacI)993780000000089225 035 $a(EXLCZ)993780000000089225 100 $a20231206d1986 uy 0 101 0 $aeng 135 $aur||||||||||| 181 $ctxt$2rdacontent 182 $cc$2rdamedia 183 $acr$2rdacarrier 200 10$aANSI/IEEE Std 80-1986 $eIEEE guide for safety in AC substation grounding /$fInstitute of Electrical and Electronics Engineers 210 1$aPiscataway, New Jersey :$cIEEE,$d1986. 215 $a1 online resource 330 $aOutdoor AC substations, either conventional or gas-insulated, are covered in this guide. Distribution, transmission, and generating plant substations are also included. With proper caution, the methods described herein are also applicable to indoor portions of such substations, or to substations that are wholly indoors. No attempt is made to cover the grounding problems peculiar to dc substations. A quantitative analysis of the effects of lightning surges is also beyond the scope of this guide. 517 $aANSI/IEEE Std 80-1986: IEEE Guide for Safety in AC Substation Grounding 606 $aElectric currents$xGrounding 606 $aElectric power transmission$xAlternating current 606 $aElectric substations 615 0$aElectric currents$xGrounding. 615 0$aElectric power transmission$xAlternating current. 615 0$aElectric substations. 676 $a621.317 801 0$bNjHacI 801 1$bNjHacl 906 $aDOCUMENT 912 $a996279567203316 996 $aANSI$92072434 997 $aUNISA LEADER 05237nam 22007815 450 001 9910853988703321 005 20250807143433.0 010 $a981-9989-49-3 024 7 $a10.1007/978-981-99-8949-2 035 $a(MiAaPQ)EBC31251686 035 $a(Au-PeEL)EBL31251686 035 $a(CKB)31364428300041 035 $a(MiAaPQ)EBC31267128 035 $a(DE-He213)978-981-99-8949-2 035 $a(Au-PeEL)EBL31267128 035 $a(OCoLC)1429724904 035 $a(EXLCZ)9931364428300041 100 $a20240403d2024 u| 0 101 0 $aeng 135 $aurcnu|||||||| 181 $ctxt$2rdacontent 182 $cc$2rdamedia 183 $acr$2rdacarrier 200 10$aPharmacovigilance Essentials $eAdvances, Challenges and Global Perspectives /$fedited by Mukesh Nandave, Anoop Kumar 205 $a1st ed. 2024. 210 1$aSingapore :$cSpringer Nature Singapore :$cImprint: Springer,$d2024. 215 $a1 online resource (478 pages) 225 1 $aMedicine Series 311 08$a981-9989-48-5 327 $aChapter 1_ Introduction to Pharmacovigilance -- Chapter 2_ History of Pharmacovigilance and Regulatory Actions -- Chapter 3_ Databases Used in Pharmacovigilance Across the Globe -- Chapter 4_ Processing of ADRs -- Chapter 5_ Signal Detection and Aggregate Reporting -- Chapter 6_ Reporting of ADRs across the globe -- Chapter 7_ Pharmacovigilance System in India. - Chapter 8_ Pharmacovigilance System in EU -- Chapter 9_ Pharmacovigilance System in USA -- Chapter 10_ Pharmacovigilance System in non-EU Countries -- Chapter 11_ Vaccine Safety Surveillance -- Chapter 12_ Herbovigilance -- Chapter 13_ Materiovigilance -- Chapter 14_ Hemovigilance -- Chapter 15_ Role of Pharmacogenetics in Pharmacovigilance -- Chapter 16_ Signal Detection and Assessment in Pharmacovigilance -- Chapter 17_ Role of Artificial Intelligence in Pharmacovigilance -- Chapter 18_ Current Challenges and Future Perspectives. 330 $aThe book explores the field of pharmacovigilance, its historical context, along with its critical role in ensuring the safety of medications across the world. From its foundational principles to cutting-edge advancements and future challenges, this book provides a thorough understanding of the field's intricacies. The book begins by establishing the fundamentals of pharmacovigilance, emphasizing its significance in monitoring, detecting, assessing, and preventing adverse drug reactions (ADRs) that occur during the use of medications. Delving into the history of pharmacovigilance and regulatory actions, the book traces the evolution of the field, highlighting significant milestones and the establishment of regulatory frameworks that govern medication safety. It explores the pivotal role of regulatory authorities in developing guidelines, regulations, and policies to safeguard public health. A significant aspect covered in the book is the processing of ADRs, providing insights into the steps involved in handling and evaluating ADR reports. The book also addresses specialized areas within pharmacovigilance, including vaccine safety surveillance, herbovigilance (monitoring the safety of herbal medicines), materiovigilance (monitoring the safety of medical devices), and hemovigilance (ensuring the safety of blood products). Additionally, the book explores the role of pharmacogenetics in pharmacovigilance, highlighting how genetic factors influence individual responses to medications and how this knowledge can be integrated into safety monitoring and risk assessment. This book also covers databases used in pharmacovigilance across the globe, aggregate reporting and pharmacovigilance systems in EU and non-EU countries, and the role of artificial intelligence. Finally, it emphasizes the need for continuous improvement, vigilance, and proactive measures to adapt to the changing healthcare landscape and address emerging safety concerns. The book serves as a comprehensive guide for healthcare professionals, researchers, regulators, and policymakers involved in pharmacovigilance. 410 0$aMedicine Series 606 $aPharmacology 606 $aMedicine$xResearch 606 $aBiology$xResearch 606 $aPharmacovigilance 606 $aMedical sciences 606 $aPharmacy 606 $aPublic health 606 $aPharmacology 606 $aBiomedical Research 606 $aDrug Safety and Pharmacovigilance 606 $aHealth Sciences 606 $aPharmacy 606 $aPublic Health 615 0$aPharmacology. 615 0$aMedicine$xResearch. 615 0$aBiology$xResearch. 615 0$aPharmacovigilance. 615 0$aMedical sciences. 615 0$aPharmacy. 615 0$aPublic health. 615 14$aPharmacology. 615 24$aBiomedical Research. 615 24$aDrug Safety and Pharmacovigilance. 615 24$aHealth Sciences. 615 24$aPharmacy. 615 24$aPublic Health. 676 $a363.19463 700 $aNandave$b Mukesh$01737180 701 $aKumar$b Anoop$01424384 801 0$bMiAaPQ 801 1$bMiAaPQ 801 2$bMiAaPQ 906 $aBOOK 912 $a9910853988703321 996 $aPharmacovigilance Essentials$94158386 997 $aUNINA